Trial
NCT03216187
Swiss Multi-centre, Randomized, Placebo Controlled Trial of Pregabalin for Prevention of Persistent Pain in High Risk Patients Undergoing Breast Cancer Surgery
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Benno Rehberg-Klug
Collaborators
University Hospital, Geneva; Centre Hospitalier Universitaire Vaudois; Insel Gruppe AG, University Hospital Bern
Condition
Persistent Postoperative Pain
Intervention
Pregabalin
Why stopped
insufficient funding and recruitment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-17